Search

Author/Creator Dalle, S

2. 1249PDConcomitant radiotherapy in melanoma brain metastases using the propensity score matching within the French cohort, MelBase. (23rd October 2018)

Authors:
Allayous, C; Oriano, B; Dalle, S; Mortier, L; Leccia, M-T; Guillot, B; Jeudy, G; Dutriaux, C; Lacour, J-P; Saiag, P; Brunet-Possenti, F; De Quatrebarbes, J; Stoebner, P-E; Legoupil, D; Beylot-Barry, M; Lesimple, T; Aubin, F; Ballon, A; Porcher, R; Lebbe, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1278PHealth-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: An international randomized double-blind phase III trial. (23rd October 2018)

Authors:
Coens, C; Bottomley, A; Blank, C U; Mandala, M; Long, G V; Atkinson, V G; Dalle, S; Haydon, A; Lichinitser, M; Khattak, A; Carlino, M S; Sandhu, S K; Larkin, J; Puig Sarda, S; Ascierto, P A; Schadendorf, D; Ibrahim, N; Suciu, S; Robert, C; Eggermont, A M M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial. (September 2022)

Authors:
Bagot, M; Muller, M; Kim, YH; Ortiz-Romero, PL; Zinzani, PL; Beylot-Barry, M; Dalle, S; Jacobsen, E; Combalia, A; Huen, A; Mehta-Shah, N; Khodadoust, MS; Viotti, J; Paiva, C; Porcu, P
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗